首页> 中文期刊> 《中国继续医学教育》 >老年下呼吸道感染铜绿假单胞菌的临床检测与耐药性调查分析

老年下呼吸道感染铜绿假单胞菌的临床检测与耐药性调查分析

         

摘要

Objective To investigate the clinical detection and drug resistance of Pseudomonas aeruginosa in elderly patients with lower respiratory tract infection.Methodsclinical examination was carried out in 102 cases of patients, and the drug resistance was investigated. ResultsThe resistance rate of the top three ranked from high to low as sulfamethoxazole, cefazolin, ceftriaxone. The sensitive rate of four from high to low were imipenem, Amikacin, ciprofloxacin, piperacillin. 102 cases of elderly patients with lower respiratory tract infections in patients with pseudomonas aeruginosa in accordance with the results of drug sensitivity test to give sensitive antibiotic treatment, cure, improve, invalid each accounted for 60.79%, 33.33%, 5.88%.Conclusion In the elderly patients with lower respiratory tract infection of Pseudomonas aeruginosa, early clinical detection, combined with drug sensitivity test results, select the appropriate sensitive antibiotic therapy, has important clinical value.%目的:探究老年下呼吸道感染铜绿假单胞菌的临床检测与耐药性调查分析。方法102例患者均实行临床检测,并对其耐药性实行调查。结果耐药率前三位从高到低依次为复方磺胺、头孢唑林、头孢曲松。而敏感率前四位从高到低依次为亚胺培南、阿米卡星、环丙沙星、哌拉西林。102例老年铜绿假单胞菌下呼吸道感染患者依照药敏试验结果给予敏感抗生素治疗,治愈、好转、无效各占60.79%、33.33%、5.88%。结论老年下呼吸道感染铜绿假单细胞菌,早期实行临床检测,并结合药敏试验结果,选择适宜的敏感抗生素治疗,具有重要的临床价值。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号